These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36610166)

  • 1. Tilianin improves lipid profile and alleviates atherosclerosis in ApoE
    Du Y; Xi M; Li Y; Zheng R; Ding X; Li X; Zhang X; Wang L; Xing J; Hong B
    Phytomedicine; 2023 Jan; 109():154577. PubMed ID: 36610166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hawthorn leaf flavonoids alleviate the deterioration of atherosclerosis by inhibiting SCAP-SREBP2-LDLR pathway through sPLA2-ⅡA signaling in macrophages in mice.
    Bai X; Wang S; Shu L; Cao Q; Hu H; Zhu Y; Chen C
    J Ethnopharmacol; 2024 Jun; 327():118006. PubMed ID: 38442806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.
    Tavori H; Giunzioni I; Predazzi IM; Plubell D; Shivinsky A; Miles J; Devay RM; Liang H; Rashid S; Linton MF; Fazio S
    Cardiovasc Res; 2016 May; 110(2):268-78. PubMed ID: 26980204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
    Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
    Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinic acid regulated TMA/TMAO-related lipid metabolism and vascular endothelial function through gut microbiota to inhibit atherosclerotic.
    Jin Q; Zhang C; Chen R; Jiang L; Li H; Wu P; Li L
    J Transl Med; 2024 Apr; 22(1):352. PubMed ID: 38622667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dingxin Recipe IV attenuates atherosclerosis by regulating lipid metabolism through LXR-α/SREBP1 pathway and modulating the gut microbiota in ApoE
    Zhang Y; Gu Y; Chen Y; Huang Z; Li M; Jiang W; Chen J; Rao W; Luo S; Chen Y; Chen J; Li L; Jia Y; Liu M; Zhou F
    J Ethnopharmacol; 2021 Feb; 266():113436. PubMed ID: 33011372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin treatment prevents SREBP2-mediated cholesterol uptake and improves lipid homeostasis during oxidative stress-induced atherosclerosis.
    Gopoju R; Panangipalli S; Kotamraju S
    Free Radic Biol Med; 2018 Apr; 118():85-97. PubMed ID: 29499335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of Plasma Prekallikrein Decreases Low-Density Lipoprotein Cholesterol by Stabilizing Low-Density Lipoprotein Receptor and Protects Against Atherosclerosis.
    Wang JK; Li Y; Zhao XL; Liu YB; Tan J; Xing YY; Adi D; Wang YT; Fu ZY; Ma YT; Liu SM; Liu Y; Wang Y; Shi XJ; Lu XY; Song BL; Luo J
    Circulation; 2022 Mar; 145(9):675-687. PubMed ID: 35189703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hawthorn (Crataegus pinnatifida Bunge) leave flavonoids attenuate atherosclerosis development in apoE knock-out mice.
    Dong P; Pan L; Zhang X; Zhang W; Wang X; Jiang M; Chen Y; Duan Y; Wu H; Xu Y; Zhang P; Zhu Y
    J Ethnopharmacol; 2017 Feb; 198():479-488. PubMed ID: 28119096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
    Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
    Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARP-1 inhibitor alleviates liver lipid accumulation of atherosclerosis
    Sheng Y; Meng G; Zhou Z; Du R; Wang Y; Jiang M
    Mol Omics; 2023 Aug; 19(7):560-573. PubMed ID: 37249474
    [No Abstract]   [Full Text] [Related]  

  • 13. PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE.
    Ason B; van der Hoorn JW; Chan J; Lee E; Pieterman EJ; Nguyen KK; Di M; Shetterly S; Tang J; Yeh WC; Schwarz M; Jukema JW; Scott R; Wasserman SM; Princen HM; Jackson S
    J Lipid Res; 2014 Nov; 55(11):2370-9. PubMed ID: 25258384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Danhong injection inhibits the development of atherosclerosis in both Apoe⁻/⁻ and Ldlr⁻/⁻ mice.
    Chen Y; Liu M; Zhao T; Zhao B; Jia L; Zhu Y; Zhang B; Gao X; Li G; Li X; Xiang R; Han J; Duan Y
    J Cardiovasc Pharmacol; 2014 May; 63(5):441-52. PubMed ID: 24803317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression profiles of lipid metabolism-related genes in liver of apoE(-/-)/LDLR(-/-) mice].
    Du HQ; Yin M; Ye HY; Shang YJ; Dai XD; Jing W; Zhang L; Xiao N; Li JF; Pan J
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):751-5. PubMed ID: 18307880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tanshinone IIA Promotes Macrophage Cholesterol Efflux and Attenuates Atherosclerosis of apoE-/- Mice by Omentin-1/ABCA1 Pathway.
    Tan YL; Ou HX; Zhang M; Gong D; Zhao ZW; Chen LY; Xia XD; Mo ZC; Tang CK
    Curr Pharm Biotechnol; 2019; 20(5):422-432. PubMed ID: 30947667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xinmaikang (XMK) tablets alleviate atherosclerosis by regulating the SREBP2-mediated NLRP3/ASC/Caspase-1 signaling pathway.
    Hou C; Jiang X; Sheng W; Zhang Y; Lin Q; Hong S; Zhao J; Wang T; Ye X
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117240. PubMed ID: 37777030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expressions of atherosclerosis-related genes in aorta in young apoE/LDLR double knockout mice].
    Dai XD; Yin M; Jing W; DU HQ; Ye HY; Shang YJ; Zhang L; Zou YY; Qu ZP; Pan J
    Sheng Li Xue Bao; 2008 Feb; 60(1):43-50. PubMed ID: 18288357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR-/- and apoE-/- mice.
    Hartman HB; Gardell SJ; Petucci CJ; Wang S; Krueger JA; Evans MJ
    J Lipid Res; 2009 Jun; 50(6):1090-100. PubMed ID: 19174369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Sirt1 activator SRT3025 provides atheroprotection in Apoe-/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression.
    Miranda MX; van Tits LJ; Lohmann C; Arsiwala T; Winnik S; Tailleux A; Stein S; Gomes AP; Suri V; Ellis JL; Lutz TA; Hottiger MO; Sinclair DA; Auwerx J; Schoonjans K; Staels B; Lüscher TF; Matter CM
    Eur Heart J; 2015 Jan; 36(1):51-9. PubMed ID: 24603306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.